scholarly journals A Randomized, Double‐Blind, Parallel‐Group, Phase 1 Clinical Trial Comparing the Pharmacokinetic, Safety, and Immunogenicity of the Biosimilar HS016 and the Originator Adalimumab in Chinese Healthy Male Subjects

2020 ◽  
Author(s):  
Guoying Cao ◽  
Jicheng Yu ◽  
Jufang Wu ◽  
Jingjing Wang ◽  
Yu Xue ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Phase 1 ◽  
Healthy Male ◽  
Double Blind ◽  
Phase 1 Clinical Trial ◽  
Parallel Group ◽  
Male Subjects

scholarly journals Safety and immunogenicity of a highly attenuated rVSVN4CT1-EBOVGP1 Ebola virus vaccine: a randomised, double-blind, placebo-controlled, phase 1 clinical trial

2020 ◽  
Vol 20 (4) ◽  
pp. 455-466 ◽  
Author(s):  
David K Clarke ◽  
Rong Xu ◽  
Demetrius Matassov ◽  
Theresa E Latham ◽  
Ayuko Ota-Setlik ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Virus Vaccine ◽  
Ebola Virus ◽  
Phase 1 ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Phase 1 Clinical Trial

884: Phase I, Double-Blind, Placebo-Controlled Study in Healthy Male Subjects to Investigate the Safety, Tolerability, and Pharmacokinetics of DA-8159

2004 ◽  
Vol 171 (4S) ◽  
pp. 234-234 ◽  
Author(s):  
Harin Padma-Nathan ◽  
Jae Seung Pacik ◽  
Byoung Ok Ahn ◽  
Kyung Koo Kang ◽  
Mi Young Bahng ◽  
...  
Keyword(s):  
Phase I ◽  
Controlled Study ◽  
Healthy Male ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Male Subjects
Sign in / Sign up

Export Citation Format

Share Document